ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 626540 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 626540; 2) Community: the network communities that were significantly associated with the response to NSC 626540; 3) Molecule: the relationships between components within communities and NSC 626540; 4) MDR: the compounds that were significantly associated with the NSC 626540.

NSC Compound Enrichment Correlation
NSC 749379 Null 0.00180188182321727 0.57727225
NSC 763646 (E)-2-(2-(benzo[d][1,3]dioxol-5-yl)vinyl)-5-(3-methyl-1H-pyrazol-5-yl)-1,3,4-oxadiazole 0.00180188182321727 0.32766375
NSC 117281 ANTINEOPLASTIC-117281 0.00182957917645006 0.48069779
NSC 166588 METHYLUNDECYLPIPERIDINE, TRANS 0.00182957917645006 0.46384956
NSC 23416 Null 0.00182957917645006 0.29391085
NSC 335794 1-Piperazinecarbothioic acid, 4-(2-pyridinyl)-, [1-(2-pyridinyl)butylidene]hydrazide 0.00182957917645006 0.45072085
NSC 376265 Piperazine-1-carbothioic acid, 4-cycloheptyl-, [1-(2-pyridyl)ethylidene]hydrazide 0.00182957917645006 0.46870094
NSC 605440 Isothiazolo[2,3-a]azepine, 5,7-bis(trifluoromethyl)- 2,3-dihydro-, 1,1-dioxide 0.00182957917645006 0.66799804
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.00182957917645006 0.58633082
NSC 624172 Null 0.00182957917645006 0.4714157
Total:149  Current:20    [First] [Prev] [Next] [Last]